Anne-marije M. Hulshof

Maastricht, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Whole genome sequencing to elucidate novel genetic modifiers of FVIII clearance.

Whole genome sequencing to elucidate novel genetic modifiers of FVIII clearance.

Journal: Blood
Published: February 13, 2026

Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohort.

Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohort.

Journal: Thrombosis research
Published: January 29, 2026

In situ pulmonary thrombosis and pulmonary embolus are distinct thrombotic phenotypes in critically ill patients with COVID-19 Acute Respiratory Distress Syndrome.

In situ pulmonary thrombosis and pulmonary embolus are distinct thrombotic phenotypes in critically ill patients with COVID-19 Acute Respiratory Distress Syndrome.

Journal: Journal of thrombosis and haemostasis : JTH
Published: July 22, 2025

Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program.

Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program.

Journal: Blood advances
Published: April 04, 2025

The Maastricht Intensive Care COVID Cohort: A Critical Appraisal of the Predefined Research Questions.

The Maastricht Intensive Care COVID Cohort: A Critical Appraisal of the Predefined Research Questions.

Journal: Critical care explorations
Published: February 03, 2025

Clinical phenotype and pathophysiological mechanisms underlying qualitative low VWF.

Clinical phenotype and pathophysiological mechanisms underlying qualitative low VWF.

Journal: Blood
Published: December 11, 2024

Exploration of the plasma proteomic profile of patients at risk of thromboembolic events.

Exploration of the plasma proteomic profile of patients at risk of thromboembolic events.

Journal: Research and practice in thrombosis and haemostasis
Published: December 06, 2024

The interleukin-33 receptor (ST2) is a novel therapeutic target to attenuate the progression of hemophilic arthropathy.

The interleukin-33 receptor (ST2) is a novel therapeutic target to attenuate the progression of hemophilic arthropathy.

Journal: Blood
Published: November 06, 2024

R1205H (Vicenza) causes conformational changes in the von Willebrand factor D'D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI.

R1205H (Vicenza) causes conformational changes in the von Willebrand factor D'D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI.

Journal: Journal of thrombosis and haemostasis : JTH
Published: April 25, 2024

Comparison of the Quantra QPlus and ROTEM Goal-Directed Transfusion Protocols in Cardiothoracic Surgery Patients: A Prospective Observational Study.

Comparison of the Quantra QPlus and ROTEM Goal-Directed Transfusion Protocols in Cardiothoracic Surgery Patients: A Prospective Observational Study.

Journal: Journal of cardiothoracic and vascular anesthesia
Published: January 25, 2024

Higher levels of circulating desphospho-uncarboxylated matrix Gla protein over time are associated with worse survival: the prospective Maastricht Intensive Care COVID cohort.

Higher levels of circulating desphospho-uncarboxylated matrix Gla protein over time are associated with worse survival: the prospective Maastricht Intensive Care COVID cohort.

Journal: Journal of intensive care
Published: August 30, 2023

Rotational thromboelastometry as a biomarker for mortality - The Maastricht Intensive Care COVID cohort.

Rotational thromboelastometry as a biomarker for mortality - The Maastricht Intensive Care COVID cohort.

Journal: Thrombosis research
Published: July 18, 2023
Showing 1-12 of 21

Last Updated: 09/26/2026